No. J1596 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code.

What NDCs are billed under J1596?

CMS's ASP crosswalk for October 1, 2026 through December 31, 2026 lists 86 NDCs under J1596, for Glycopyrrolate Injection. The table on this page shows each one with its billing units per package.

What is the Medicare payment limit for J1596?

$0.33 per 0.1 mg, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.

What is one billing unit of J1596?

One unit of J1596 is 0.1 mg, as stated in the code's descriptor. Units to report = dose given ÷ 0.1 mg.

J1596 J-Code: Glycopyrrolate — Billing Units & NDCs

In short

J1596 is the HCPCS Level II code for injection, glycopyrrolate, 0.1 mg. CMS assigns NDCs for Glycopyrrolate Injection to it. One billing unit is 0.1 mg. The Medicare Part B payment limit is $0.33 per unit (October 1, 2026 through December 31, 2026).

Code

CMS HCPCS file

HCPCS codeJ1596

Billing unit0.1 mg

Descriptor: Injection, glycopyrrolate, 0.1 mg
Short descriptor: Inj, glycopyrrolate, 0.1 mg
Code set: HCPCS Level II, maintained by CMS
Effective: Jan 1, 2025

The billing unit is read from the descriptor. Confirm it against the CMS file before billing.

Medicare Part B payment limit

CMS ASP file

Payment limit per unit$0.33

Per0.1 mg

Coinsurance20%

Effective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files

Units and claim line

Units = dose given ÷ 0.1 mg. For example, 10 mg is 100 units. Enter the dose to get the units and the NDC line for the CMS-1500 and the 837P.

Dose given (mg)

HCPCS units (1 unit = 0.1 mg)

Modifier

NDC (11-digit)

NDC unit qualifier

NDC quantity

Enter the dose given to build the claim line.

NDCs billed under J1596

CMS’s ASP NDC–HCPCS crosswalk (effective October 1, 2026 through December 31, 2026) assigns 86 NDCs to J1596 for Glycopyrrolate Injection. Billing units per package are CMS’s figures for this code’s unit.

NDCs assigned to J1596 in the CMS ASP crosswalk
Drug	NDC (11-digit)	Labeler	Package	Billing units per package
Glycopyrrolate Injection	00143-9584-10	Hikma Pharmaceuticals USA Inc.	10 × 20	400
Glycopyrrolate Injection	00143-9585-25	Hikma Pharmaceuticals USA Inc.	25 × 5	250
Glycopyrrolate Injection	00143-9586-25	Hikma Pharmaceuticals USA Inc.	25 × 2	100
Glycopyrrolate Injection	00143-9587-25	Hikma Pharmaceuticals USA Inc.	25 × 1	50
Glycopyrrolate Injection	00143-9679-10	Hikma Pharmaceuticals USA Inc.	10 × 20	400
Glycopyrrolate Injection	00143-9680-25	Hikma Pharmaceuticals USA Inc.	25 × 5	250
Glycopyrrolate Injection	00143-9681-25	Hikma Pharmaceuticals USA Inc.	25 × 2	100
Glycopyrrolate Injection	00143-9682-25	Hikma Pharmaceuticals USA Inc.	25 × 1	50
Glycopyrrolate Injection	00404-9775-01	Henry Schein Inc.	1	2
Glycopyrrolate Injection	00404-9776-05	Henry Schein Inc.	5	10
Glycopyrrolate Injection	00404-9777-20	Henry Schein Inc.	20	40
Glycopyrrolate Injection	00404-9782-02	Henry Schein Inc.	2	4
Glycopyrrolate Injection	00404-9867-01	Henry Schein Inc.	1	2
Glycopyrrolate Injection	00404-9868-20	Henry Schein Inc.	20	40
Glycopyrrolate Injection	00404-9869-02	Henry Schein Inc.	2	4
Glycopyrrolate Injection	00404-9870-05	Henry Schein Inc.	5	10
Glycopyrrolate Injection	00517-4601-25	American Regent, Inc.	25 × 1	50
Glycopyrrolate Injection	00517-4602-25	American Regent, Inc.	25 × 2	100
Glycopyrrolate Injection	00517-4605-25	American Regent, Inc.	25 × 5	250
Glycopyrrolate Injection	00517-4620-25	American Regent, Inc.	25 × 20	1,000
Glycopyrrolate Injection	00641-6212-10	Hikma Pharmaceuticals USA Inc.	10 × 1	20
Glycopyrrolate Injection	00641-6213-10	Hikma Pharmaceuticals USA Inc.	10 × 2	40
Glycopyrrolate Injection	00781-3825-96	Sandoz Inc.	25 × 1	50
Glycopyrrolate Injection	00781-3827-96	Sandoz Inc.	25 × 2	100
Glycopyrrolate Injection	00781-3829-96	Sandoz Inc.	25 × 5	250
Glycopyrrolate Injection	00781-3831-95	Sandoz Inc.	10 × 20	400
Glycopyrrolate Injection	25021-0796-01	Sagent Pharmaceuticals	25 × 1	50
Glycopyrrolate Injection	25021-0796-02	Sagent Pharmaceuticals	25 × 2	100
Glycopyrrolate Injection	25021-0796-05	Sagent Pharmaceuticals	25 × 5	250
Glycopyrrolate Injection	50090-4513-00	A-S Medication Solutions	1	2
Glycopyrrolate Injection	50090-5226-00	A-S Medication Solutions	25 × 1	50
Glycopyrrolate Injection	51662-1487-01	HF Acquisition Co. LLC, DBA HealthFirst	1	2
Glycopyrrolate Injection	51662-1487-03	HF Acquisition Co. LLC, DBA HealthFirst	25 × 1	50
Glycopyrrolate Injection	51662-1554-03	HF Acquisition Co. LLC, DBA HealthFirst	25 × 2	100
Glycopyrrolate Injection	51662-1601-01	HF Acquisition Co. LLC, DBA HealthFirst	5	10
Glycopyrrolate Injection	51662-1601-03	HF Acquisition Co. LLC, DBA HealthFirst	25 × 5	250
Glycopyrrolate Injection	60505-6179-05	Apotex Corp	25 × 1	50
Glycopyrrolate Injection	60505-6180-05	Apotex Corp	25 × 2	100
Glycopyrrolate Injection	60505-6181-05	Apotex Corp	25 × 5	250
Glycopyrrolate Injection	60505-6182-04	Apotex Corp	10 × 20	400
Glycopyrrolate Injection	62332-0607-25	Alembic Pharmaceuticals Inc.	25 × 1	50
Glycopyrrolate Injection	62332-0627-25	Alembic Pharmaceuticals Inc.	25 × 2	100
Glycopyrrolate Injection	62332-0628-25	Alembic Pharmaceuticals Inc.	25 × 5	250
Glycopyrrolate Injection	62332-0629-10	Alembic Pharmaceuticals Inc.	10 × 20	400
Glycopyrrolate Injection	63323-0578-01	FreseniUS Kabi USA, LLC	25 × 1	50
Glycopyrrolate Injection	63323-0578-02	FreseniUS Kabi USA, LLC	25 × 2	100
Glycopyrrolate Injection	63323-0578-05	FreseniUS Kabi USA, LLC	25 × 5	250
Glycopyrrolate Injection	63323-0578-11	FreseniUS Kabi USA, LLC	25 × 1	50
Glycopyrrolate Injection	63323-0578-12	FreseniUS Kabi USA, LLC	25 × 2	100
Glycopyrrolate Injection	65219-0801-01	FreseniUS Kabi USA, LLC	25 × 1	50
Glycopyrrolate Injection	66794-0202-42	Piramal Critical Care Inc	25 × 1	50
Glycopyrrolate Injection	66794-0203-42	Piramal Critical Care Inc	25 × 2	100
Glycopyrrolate Injection	66794-0204-42	Piramal Critical Care Inc	25 × 5	250
Glycopyrrolate Injection	66794-0205-41	Piramal Critical Care Inc	10 × 20	400
Glycopyrrolate Injection	70069-0616-10	Somerset Pharma, LLC	10 × 20	400
Glycopyrrolate Injection	70069-0617-25	Somerset Pharma, LLC	25 × 1	50
Glycopyrrolate Injection	70069-0618-25	Somerset Pharma, LLC	25 × 2	100
Glycopyrrolate Injection	70069-0619-25	Somerset Pharma, LLC	25 × 5	250
Glycopyrrolate Injection	70121-1698-07	Amneal Pharmaceuticals, LLC	10 × 1	20
Glycopyrrolate Injection	70121-1699-07	Amneal Pharmaceuticals, LLC	10 × 2	40

Showing 60 of 86. The full list is in the CMS crosswalk file.

J1596: common questions

Is J1596 a CPT code?: No. J1596 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
What NDCs are billed under J1596?: CMS's ASP crosswalk for October 1, 2026 through December 31, 2026 lists 86 NDCs under J1596, for Glycopyrrolate Injection. The table on this page shows each one with its billing units per package.
What is the Medicare payment limit for J1596?: $0.33 per 0.1 mg, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.
What is one billing unit of J1596?: One unit of J1596 is 0.1 mg, as stated in the code's descriptor. Units to report = dose given ÷ 0.1 mg. J-code billing units.

J1596 — Injection, glycopyrrolate, 0.1 mg